Search

Displaying results 7061 - 7070 of 7555 in total
  1. Drug

    Ketazocine

    go.drugbank.com/drugs/DB20132
    Experimental

    The usage of the INN stem '-azocine' in the name indicates that Ketazocine is a narcotic antagonist/agonist related to 6,7-benzomorphan. Ketazocine has a monoisotopic molecular weight of 285.17 Da.

  2. Drug

    Ripisartan

    go.drugbank.com/drugs/DB20229
    Experimental

    The usage of the INN stem '-sartan' in the name indicates that Ripisartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic).

  3. Drug

    AD-233A

    go.drugbank.com/drugs/DB33952
    Experimental

    AD-233A is under investigation in clinical trial NCT07816198 (A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination Therapy).

  4. Drug

    AD-233C

    go.drugbank.com/drugs/DB33954
    Experimental

    AD-233C is under investigation in clinical trial NCT07816198 (A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination Therapy).

  5. Drug

    AD-233D

    go.drugbank.com/drugs/DB33955
    Experimental

    AD-233D is under investigation in clinical trial NCT07816198 (A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination Therapy).

  6. Drug

    Tertatolol

    go.drugbank.com/drugs/DB13775
    Experimental

    Tertatolol is a beta blocker.

    Categories: Beta Blocking Agents, Non-Selective
  7. Drug

    Bisphenol A

    go.drugbank.com/drugs/DB06973
    Experimental

    Categories: Estrogens, Non-Steroidal
  8. Drug

    Freneslerbart

    go.drugbank.com/drugs/DB19080
    Investigational

    Freneslerbart is under investigation in clinical trial NCT04981717 (A Study to Examine the Efficacy and Safety of Anti-fel D 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic

  9. Drug

    TMC-649128

    go.drugbank.com/drugs/DB15152
    Investigational

    TMC-649128 is under investigation in clinical trial NCT01391117 (TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics

  10. Drug

    AS-8112

    go.drugbank.com/drugs/DB09207
    Experimental

    It has been shown to exert potent antiemetic effects in animal studies and has been investigated for potential medical use.